These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7737334)

  • 41. Effects of antipsychotic drugs on extracellular dopamine levels in rat medial prefrontal cortex and nucleus accumbens.
    Kuroki T; Meltzer HY; Ichikawa J
    J Pharmacol Exp Ther; 1999 Feb; 288(2):774-81. PubMed ID: 9918588
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Atypical antipsychotic drugs, quetiapine, iloperidone, and melperone, preferentially increase dopamine and acetylcholine release in rat medial prefrontal cortex: role of 5-HT1A receptor agonism.
    Ichikawa J; Li Z; Dai J; Meltzer HY
    Brain Res; 2002 Nov; 956(2):349-57. PubMed ID: 12445705
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Serotonin, via 5-HT2A receptors, increases EPSCs in layer V pyramidal cells of prefrontal cortex by an asynchronous mode of glutamate release.
    Aghajanian GK; Marek GJ
    Brain Res; 1999 Apr; 825(1-2):161-71. PubMed ID: 10216183
    [TBL] [Abstract][Full Text] [Related]  

  • 44. M100907, a serotonin 5-HT2A receptor antagonist and putative antipsychotic, blocks dizocilpine-induced prepulse inhibition deficits in Sprague-Dawley and Wistar rats.
    Varty GB; Bakshi VP; Geyer MA
    Neuropsychopharmacology; 1999 Apr; 20(4):311-21. PubMed ID: 10088132
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Serotonin-mediated increase in prefrontal cortex dopamine release: pharmacological characterization.
    Iyer RN; Bradberry CW
    J Pharmacol Exp Ther; 1996 Apr; 277(1):40-7. PubMed ID: 8613947
    [TBL] [Abstract][Full Text] [Related]  

  • 46. 5-HT 2A receptor stimulation by DOI, a 5-HT 2A/2C receptor agonist, potentiates amphetamine-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens.
    Kuroki T; Meltzer HY; Ichikawa J
    Brain Res; 2003 May; 972(1-2):216-21. PubMed ID: 12711095
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The 5-HT receptor antagonist M100,907 prevents extracellular glutamate rising in response to NMDA receptor blockade in the mPFC.
    Ceglia I; Carli M; Baviera M; Renoldi G; Calcagno E; Invernizzi RW
    J Neurochem; 2004 Oct; 91(1):189-99. PubMed ID: 15379899
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Enhancement of antipsychoticlike properties of raclopride in rats using the selective serotonin2A receptor antagonist MDL 100,907.
    Wadenberg ML; Hicks PB; Richter JT; Young KA
    Biol Psychiatry; 1998 Sep; 44(6):508-15. PubMed ID: 9777184
    [TBL] [Abstract][Full Text] [Related]  

  • 49. AC260584 (4-[3-(4-butylpiperidin-1-yl)-propyl]-7-fluoro-4H-benzo[1,4]oxazin-3-one), a selective muscarinic M1 receptor agonist, increases acetylcholine and dopamine release in rat medial prefrontal cortex and hippocampus.
    Li Z; Bonhaus DW; Huang M; Prus AJ; Dai J; Meltzer HY
    Eur J Pharmacol; 2007 Oct; 572(2-3):129-37. PubMed ID: 17628522
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expression of 5-HT2A receptors in prefrontal cortex pyramidal neurons projecting to nucleus accumbens. Potential relevance for atypical antipsychotic action.
    Mocci G; Jiménez-Sánchez L; Adell A; Cortés R; Artigas F
    Neuropharmacology; 2014 Apr; 79():49-58. PubMed ID: 24211653
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The 5-HT2 receptor antagonist, MDL 28,133A, disrupts the serotonergic-dopaminergic interaction mediating the neurochemical effects of 3,4-methylenedioxymethamphetamine.
    Schmidt CJ; Black CK; Taylor VL; Fadayel GM; Humphreys TM; Nieduzak TR; Sorensen SM
    Eur J Pharmacol; 1992 Sep; 220(2-3):151-9. PubMed ID: 1425989
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Regional effects of MK-801 on dopamine release: effects of competitive NMDA or 5-HT2A receptor blockade.
    Schmidt CJ; Fadayel GM
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1541-9. PubMed ID: 8667221
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dissociable contribution of 5-HT1A and 5-HT2A receptors in the medial prefrontal cortex to different aspects of executive control such as impulsivity and compulsive perseveration in rats.
    Carli M; Baviera M; Invernizzi RW; Balducci C
    Neuropsychopharmacology; 2006 Apr; 31(4):757-67. PubMed ID: 16192987
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antagonism of 5-hydroxytryptamine(2a) receptors attenuates the behavioral effects of cocaine in rats.
    McMahon LR; Cunningham KA
    J Pharmacol Exp Ther; 2001 Apr; 297(1):357-63. PubMed ID: 11259563
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Opposite control of mesocortical and mesoaccumbal dopamine pathways by serotonin
    Devroye C; Haddjeri N; Cathala A; Rovera R; Drago F; Piazza PV; Artigas F; Spampinato U
    Neuropharmacology; 2017 Jun; 119():91-99. PubMed ID: 28390892
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Serotonergic facilitation of synaptic activity in the developing rat prefrontal cortex.
    Béïque JC; Chapin-Penick EM; Mladenovic L; Andrade R
    J Physiol; 2004 May; 556(Pt 3):739-54. PubMed ID: 14742723
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ipsapirone enhances the dopamine outflow via 5-HT1A receptors in the rat prefrontal cortex.
    Wedzony K; Maćkowiak M; Fijał K; Gołembiowska K
    Eur J Pharmacol; 1996 Jun; 305(1-3):73-8. PubMed ID: 8813534
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sulpiride in combination with fluvoxamine increases in vivo dopamine release selectively in rat prefrontal cortex.
    Ago Y; Nakamura S; Baba A; Matsuda T
    Neuropsychopharmacology; 2005 Jan; 30(1):43-51. PubMed ID: 15383832
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Behavioral tolerance to lysergic acid diethylamide is associated with reduced serotonin-2A receptor signaling in rat cortex.
    Gresch PJ; Smith RL; Barrett RJ; Sanders-Bush E
    Neuropsychopharmacology; 2005 Sep; 30(9):1693-702. PubMed ID: 15756304
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The 5-hydroxytryptamine2A receptor antagonist R-(+)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl-4-piperidinemethanol (M100907) attenuates impulsivity after both drug-induced disruption (dizocilpine) and enhancement (antidepressant drugs) of differential-reinforcement-of-low-rate 72-s behavior in the rat.
    Ardayfio PA; Benvenga MJ; Chaney SF; Love PL; Catlow J; Swanson SP; Marek GJ
    J Pharmacol Exp Ther; 2008 Dec; 327(3):891-7. PubMed ID: 18772320
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.